SOD1 and amyotrophic lateral sclerosis: We have achieved one of the most impressive reductions of SOD1 (up to 80% reduction) ever reported using a treatment in the ALS SOD1G93A mouse model after disease onset, which corresponds to the period when ALS is usually diagnosed in patients.